Empowering investors with access to the best research, experts and opportunities.
9th March 2025
9th May 2025
16th May 2024
Live Investor Briefing
In this session Felix Gold Executive Director Joseph Webb discussed their plans to develop a potential multi million ounce high grade gold resource.
Speaker
DR Gerard Dyson Managing Director – Spectur Limited (ASX: SP3)
18th April 2024
In this session Far East Gold’s CEO and Director Shane Menere discussed the standout assays from our Woyla drilling campaigns that form the base of our upcoming maiden JORC resource publication.
9th April 2024
In this session Prescient CEO and Managing Director Steven Yatomi-Clarke discussed why the data from their PTX-100 Phase 1b trial is so promising.
25th March 2024
In this session Prescient CEO and Managing Director Steven Yatomi-Clarke provide a company update on strategy and upcoming milestones.
DR Gerard Dyson
Managing Director – Spectur Limited (ASX: SP3)
14th March 2024
Join Stuart Roberts, co-founder and senior analyst at Pitt Street Research, for an online briefing where he will outline the recent Pitt Street Research report on Prescient Therapeutics.
22nd February 2024
In this session Far East Gold’s CEO and Director Shane Menere discussed, why the Board (including Nickel Industries MD Justin Werner) is optimistic about the findings so far……
15th February 2024
In this session Wellnex Life MD Zack Bozinovski and Non-Executive Chairman Mario Tascone discussed what attracted Mario to Wellnex and where he sees the future of the business;
9th November 2025
7th November 2023
Far East Gold’s Chairman of the Board Paul Walker discusses the company’s six advanced porphyry-and epithermal-rich gold and copper projects across Indonesia and Australia, and its upcoming IPO opportunity.
23rd November 2022
This week we were joined by the CEOs of exciting ASX listed businesses: Credit Clear Limited (ASX: CCR) and Race Oncology Limited (ASX: RAC)
9th November 2022
Aerometrex (ASX: AMX) is a professional aerial mapping business, specialising in aerial imagery, photogrammetry, LiDAR, 3D modelling and aerial imagery subscription services.
8th November 2022
Wellnex Life Limited (ASX: WNX) an Australian brand innovation and distribution company operating within the $10.7 billion Australian health and wellness market
3rd November 2022
Prescient Therapeutics (ASX: PTX) CEO and MD Steven Yatomi-Clarke discusses how Prescient is advancing its deep pipeline, including moving OmniCAR towards clinical studies and progressing PTX-100 and PTX-200 further through the clinic. What the recent Q-Gen contract means for producing first OmniCAR T-cells for upcoming clinical trials, based on the encouraging progress of the AML program.
21st October 2022
Spectur (ASX: SP3) MD Gerard Dyson discusses how the company’s wide technological moat leaves the company with no direct competition, its weighted sales pipeline which has grown 94% year-on-year as at June 2022, and how Spectur are ready to scale and move into its next growth phase.
14th October 2022
Wellnex Life (ASX: WNX) CEO George Karafotias and CSO Zack Bozinovski provide an overview of the over-the-counter medicinal cannabis opportunity in a special investor briefing.
4th October 2022
29th September 2022
28th September 2022
By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.